4/A
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-091744
Options or other derivatives
- SVP & Chief Scientific Officer acquired 19,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-12-15 | Grant or award : show line 1 in the form Restricted Stock Unit | +10,500 | 2023-12-14 | 10,500 | 10,500 | D | |
| 2015-12-15 | Grant or award : show line 2 in the form Stock Option | +8,750 | $15.55 | 2023-12-14 | 8,750 | 8,750 | D |
Loading xslF345X03/doc4a.xml…